Are Options Traders Betting on a Big Move in Colgate-Palmolive Stock?

Colgate-Palmolive options show heightened expectations for a big move: the Aug. 21, 2026 $40 call carries some of the highest implied volatility among equity options. At the same time, sell-side momentum is soft—no analyst raised current-quarter earnings estimates over the past 60 days, while three cut them, nudging the Zacks consensus EPS estimate down from $0.96 to $0.95. The article frames the elevated volatility as potentially presenting an options-premium/decay trade rather than a clear fundamental catalyst.

Analysis

The setup looks more like a positioning event than a clean fundamental re-rating. In a low-beta staple, a single strike showing outsized implied volatility usually means the street is paying up for convexity because of an unknown catalyst, not because it has conviction in sustained earnings acceleration. With consensus already drifting lower, the burden of proof is on CL to show margin resilience and pricing power; otherwise the option premium is likely overpaying for a move that does not materialize.

Competitive dynamics still matter here: if CL is being bid for upside optionality, that is often a sign of perceived relative under-ownership versus peers rather than true operating improvement. The more interesting read-through is to PG and KMB: if CL is seeing estimate pressure while vol spikes, the market may be extrapolating weaker category demand, FX drag, or promotional intensity across the staples basket. That creates a relative-value opportunity more than a directional one.

The main risk is timing. Over days to weeks, a surprise earnings date, guidance revision, or a flow-driven squeeze can overpower the weak fundamentals signal. Over 1-3 months, continued estimate cuts should compress the multiple and bleed rich call premium; over 6-18 months, only a re-acceleration in organic sales or a margin inflection would justify paying this level of optionality. What would falsify the bearish read is any upward EPS revision, clearer volume stabilization, or a sustained drop in implied volatility without the stock breaking higher.

Key Decisions for Investors

• Prefer selling volatility over buying it: if no earnings/event is within the next 30-45 days, consider a small CL call spread overwrite or covered-call structure against existing long stock; target vol mean reversion and cap upside risk rather than paying elevated premium.
• Relative-value pair: long PG / short CL over 1-3 months if you want consumer-staples exposure. Thesis is that CL’s estimate drift and richer optionality reflect weaker near-term operating momentum than best-in-class peers.
• Watchlist alert, not a full recommendation: if CL’s implied volatility remains elevated after the next catalyst and open interest is concentrated in the Aug. 2026 $40 strike, short a defined-risk call spread only after confirmation that the move is flow-driven rather than earnings-driven.
• If CL trades below recent support after the next guidance event, use a small bearish put spread rather than outright short stock; the name is still defensive, so downside is likely more about de-rating than collapse.
• Falsifier to the thesis: any positive earnings revision or raised guidance; if that occurs, cover volatility shorts immediately and reassess for a squeeze back toward the call strike.